Biotech

All Articles

Vertex, beaten through AATD again, loses 2 assets on throw out pile

.Vertex's attempt to alleviate a rare hereditary ailment has actually attacked one more trouble. The...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Biotechnology's second-quarter incomes document wasn't except large headlines. The company welc...

Galapagos stops CAR-T cell treatment litigation over Parkinsonism case

.Galapagos has actually paused registration in a test of a BCMA-directed CAR-T cell treatment, pushi...

James Wilson leaving behind Penn to release pair of brand-new biotechs

.After much more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving be...

3 biotechs attempt to trump the summertime warm by dropping team

.As biotechs attempt to transform a fresh web page in August, at least three business have actually ...

venBio raises $528M for 5th life scientific researches VC fund

.Veteran venture capital company venBio has raised yet another half a billion dollars to buy biotech...

Otsuka pays for $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Pharmaceutical has gotten Boston-based Jnana Therapeutics for $800 million so the Oriental b...

FibroGen gives up 75% people workers as asset fails 2 more trials

.FibroGen is substantially reorganizing its own company, giving up 75% of its own U.S. staff and cea...

Tracon unwind weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has made a decision to wane functions weeks after an injectable immune syste...

Ideaya bags choice on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...